Format

Send to

Choose Destination
See comment in PubMed Commons below
J Cardiovasc Electrophysiol. 2003 Sep;14(9 Suppl):S30-4.

Resynchronization therapy is an important advance in the management of congestive heart failure: view of an antagonist.

Author information

  • 1Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. jessupm@uphs.upenn.edu

Abstract

The antagonist portion of the debate acknowledges that cardiac resynchronization therapy (CRT) is an important advance in the management of congestive heart failure, but the eligible treatment population currently is small relative to the whole. The impact of CRT on mortality without an implantable cardioverter defibrillator (ICD) probably is not significant, although a beneficial effect on morbidity associated with heart failure has clearly been achieved. The costs of CRT are not negligible. The morbidity and mortality of the procedure to implant these devices must be considered in future trial design.

PMID:
12950515
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center